Active, not recruitingPhase 2NCT01920737

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Memorial Sloan Kettering Cancer Center
Principal Investigator
Jae Park, MD
Memorial Sloan Kettering Cancer Center
Intervention
Daunorubicin(drug)
Enrollment
39 enrolled
Eligibility
18-60 years · All sexes
Timeline
20132026

Study locations (3)

Collaborators

Shire · Duke University · Weill Medical College of Cornell University · Lehigh Valley Health Network

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01920737 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials